# HFNO VERSUS BIPAP IN PREECLAMPTIC PATIENTS WITH ACUTE HYPOXAEMIC RESPIRATORY FAILURE

> **NCT07084870** · NA · COMPLETED · sponsor: **Alexandria University** · enrollment: 60 (actual)

## Conditions studied

- HFNO vs BIPAP
- Preeclamptic Acute Hypoxaemic Respiratory Failure

## Interventions

- **OTHER:** High flow nasal oxygen
- **OTHER:** non invasive BIPAP

## Key facts

- **NCT ID:** NCT07084870
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2025-03-20
- **Final completion:** 2025-03-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07084870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07084870, "HFNO VERSUS BIPAP IN PREECLAMPTIC PATIENTS WITH ACUTE HYPOXAEMIC RESPIRATORY FAILURE". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07084870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*